Vivek Balasubramaniam, MD

Education

BS, University of California Los Angeles, Los Angeles, California
MD, University of Pittsburgh, Pittsburgh, Pennsylvania
Residency, Pediatrics, University of Pittsburgh, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
Fellowship, Pediatric Pulmonology and Pediatric Critical Care, University of Colorado, Children’s Hospital of Denver, Denver, Colorado

Professional Activities

Dr. Vivek Balasubramaniam is associate professor (CHS) in the Division of Pulmonology and Sleep Medicine. He is a physician-scientist and National Institutes of Health (NIH)-funded researcher with a passion for pulmonary physiology and child health advocacy. Balasubramaniam is the clinical leader of programs in bronchopulmonary dysplasia, pulmonary hypertension, childhood interstitial lung disease, and pediatric aerodigestive disease. Professionally, he strives to bring together cutting-edge science and clinical care while using both to advocate on a national level for improved child health. 

Clinical Interests

Balasubramaniam is a pediatric pulmonologist with clinical interests in the mechanism and treatment of impaired lung function in infants born prematurely with bronchopulmonary dysplasia (BPD). Through his clinical practice, Balasubramaniam seeks to understand the dysfunction of the development or function of the gas exchange region of the lung that is affected by chronic injury and inflammation. He pursues his interest in disorders of the upper airway and digestive system that affect children through his leadership of the Pediatric Aerodigestive Care Team (PACT). 

Research Interests

Balasubramaniam’s background in cell and molecular biology led to his interest in investigating the mechanisms of lung vascular growth and function during normal development and with lung injury. He previously led a pre-clinical research laboratory that used small animal models of BPD and in vitro cell culture to explore the role of stem and progenitor cells in the development of and recovery from neonatal lung injury. Currently, Balasubramaniam participates in clinical and translational research in neonatal lung and vascular injury and interstitial lung disease.